Home Cart 0 Sign in  
X

[ CAS No. 50-43-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 50-43-1
Chemical Structure| 50-43-1
Chemical Structure| 50-43-1
Structure of 50-43-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50-43-1 ]

Related Doc. of [ 50-43-1 ]

Alternatived Products of [ 50-43-1 ]

Product Details of [ 50-43-1 ]

CAS No. :50-43-1 MDL No. :MFCD00060699
Formula : C7H3Cl3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :RAFFVQBMVYYTQS-UHFFFAOYSA-N
M.W : 225.46 Pubchem ID :5764
Synonyms :

Calculated chemistry of [ 50-43-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 48.43
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 2.86
Log Po/w (WLOGP) : 3.35
Log Po/w (MLOGP) : 3.36
Log Po/w (SILICOS-IT) : 3.16
Consensus Log Po/w : 2.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.34
Solubility : 0.102 mg/ml ; 0.000453 mol/l
Class : Soluble
Log S (Ali) : -3.3
Solubility : 0.112 mg/ml ; 0.000499 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.63
Solubility : 0.0532 mg/ml ; 0.000236 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.28

Safety of [ 50-43-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 50-43-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50-43-1 ]
  • Downstream synthetic route of [ 50-43-1 ]

[ 50-43-1 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 50-43-1 ]
  • [ 4136-95-2 ]
Reference: [1] Journal of the American Chemical Society, 1932, vol. 54, p. 4380,4382
[2] Journal of the Chemical Society, 1894, vol. 65, p. 1030
[3] Bulletin of the Chemical Society of Japan, 1979, vol. 52, p. 1989 - 1993
[4] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 2, p. 171 - 175
[5] Patent: US2010/317643, 2010, A1, . Location in patent: Page/Page column 100
[6] Patent: WO2013/72300, 2013, A1, . Location in patent: Page/Page column 123
[7] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 20, p. 5513 - 5521
  • 2
  • [ 50-43-1 ]
  • [ 217479-60-2 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With borane-dimethyl sulfide complex In tetrahydrofuran at 22℃; Inert atmosphere; Cooling with ice; Reflux
Stage #2: With methanol In tetrahydrofuran
Step 1 ) 1 4To a solution of commercially available compound 1 (22.5 g, 0.1 mol) in THF (200 mL) was added BH3-Me2S (10 M, 20 mL, 0.2 mol) under N2 with ice-cooling. The mixture was allowed to warm to 22°C and stirred overnight under reflux. Methanol (100 mL) was added drop-wise and the resulting mixture stirred for 16 g. The mixture was concentrated in vacuo to afford compound 4 (22.7 g, 100percent) as a white solid. 1H NMR (CDCIs 400MHz): ? 7.37 (s, 2H), 4.93 (d, 2H, J=6.8 Hz).
Reference: [1] Patent: WO2013/72300, 2013, A1, . Location in patent: Page/Page column 123-124
[2] Angewandte Chemie - International Edition, 2015, vol. 54, # 36, p. 10596 - 10599[3] Angew. Chem., 2015, vol. 127, p. 10742 - 10745,4
[4] Patent: US6348474, 2002, B1, . Location in patent: Page column 126
  • 3
  • [ 50-43-1 ]
  • [ 585-76-2 ]
  • [ 69038-74-0 ]
Reference: [1] Patent: US6518267, 2003, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 50-43-1 ]

Aryls

Chemical Structure| 10007-84-8

[ 10007-84-8 ]

Sodium 2,6-dichlorobenzoate

Similarity: 0.98

Chemical Structure| 13799-90-1

[ 13799-90-1 ]

2,5-Dichloroterephthalic acid

Similarity: 0.96

Chemical Structure| 83277-23-0

[ 83277-23-0 ]

2,4-Dichloro-3-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 153203-80-6

[ 153203-80-6 ]

3,5-Dichloro-4-formylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.94

Chlorides

Chemical Structure| 10007-84-8

[ 10007-84-8 ]

Sodium 2,6-dichlorobenzoate

Similarity: 0.98

Chemical Structure| 13799-90-1

[ 13799-90-1 ]

2,5-Dichloroterephthalic acid

Similarity: 0.96

Chemical Structure| 83277-23-0

[ 83277-23-0 ]

2,4-Dichloro-3-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 153203-80-6

[ 153203-80-6 ]

3,5-Dichloro-4-formylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.94

Carboxylic Acids

Chemical Structure| 13799-90-1

[ 13799-90-1 ]

2,5-Dichloroterephthalic acid

Similarity: 0.96

Chemical Structure| 83277-23-0

[ 83277-23-0 ]

2,4-Dichloro-3-methylbenzoic acid

Similarity: 0.96

Chemical Structure| 153203-80-6

[ 153203-80-6 ]

3,5-Dichloro-4-formylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 2845-85-4

[ 2845-85-4 ]

4-Chloroisophthalic acid

Similarity: 0.92